Support for genetic tests with new study

Dec 17, 2010

A majority of Australians would seek testing to establish their genetic susceptibility to depression, despite social stigma and questions about the test’s validity, a national study has found.

The study, conducted by researchers at the University of New South Wales (UNSW) and published this week in the advance online edition of the UK-based journal Psychological Medicine, is the first population-wide analysis of attitudes toward for mental illness.

The randomised phone survey of more than 1,000 Australian adults found strong community acceptance of the testing, especially if provided by a doctor.

The main drivers of interest in seeking genetic testing for risk were a personal history of depression and a self-assessment of being at higher-than-average risk, the study found.

“The findings are surprising given that we also found widespread belief that genetic links to mental illness would increase rather than decrease stigma and also because the validity and utility of the testing is still in question,” said study lead-author Dr. Alex Wilde, from UNSW’s School of Psychiatry.

“There is no certainty depression will manifest in someone with a higher-than-average risk whether they are exposed to stressful life events or not. The results reflect a prevailing belief that the benefits of knowing one’s own outweigh the risks,” she said.

The most frequently endorsed benefit was the belief that testing could facilitate prevention and early intervention of a major depressive disorder.

The most endorsed disadvantage was the fear that insurance companies or employers would discriminate against people who returned a positive result.

Significantly, there was a much greater interest in seeking genetic tests for depression risk through a doctor (63%) compared to direct-to-consumer (40%), although interest in direct-to-consumer genetic testing persisted.

“The topic of genetic testing for common disorders has been subject to continuing interest all over the world since the rise, fall, and rise again of the unregulated direct-to-consumer market,” Dr. Wilde said.

“This is especially so given the lack of genetic non-discrimination laws in Australia and inadequacy of such laws in Europe and the USA.”

Many genetic tests currently offered direct-to-consumer involve unreplicated gene-disease associations and have uncertain predictive value and clinical utility, Dr. Wilde said.

While several governments have issued a ban on marketing genetic tests for common complex disorders directly to consumers in the absence of appropriate regulations, the tests are freely available online.

“Considering direct-to-consumer genetic tests are marketed internationally, consumers may have no legal protection from genetic discrimination for insurance or employment in their own country,” Dr. Wilde said.

“These findings highlight that while any future genetic susceptibility testing for depression risk as an intervention tool for target groups is likely to be acceptable to the general community, they indicate the need for appropriate legislation to prevent genetic discrimination. There is also a need for further research to see how information about genetic susceptibility might be best used in health care.”

Explore further: Why some antidepressants may initially worsen symptoms

add to favorites email to friend print save as pdf

Related Stories

Depression not so clear cut for teens

Oct 12, 2010

Teenagers think mental illness carries much more stigma than it actually does, according to new research from The Australian National University.

Wide genetic testing for Lynch Syndrome cost effective

Nov 19, 2010

Widespread genetic testing for Lynch Syndrome appears to be a cost-effective strategy for identifying those at risk for colorectal and endometrial cancer, according to a report in Cancer Prevention Research, a journal of the ...

At Home Genomic Tests for Disease Risk Premature

Mar 18, 2008

The recent marketing of "at home" genomic tests for disease risk may be premature, according to Dr. Kenneth Offit, MD, MPH, Chief of the Clinical Genetics Service at Memorial Sloan-Kettering Cancer Center (MSKCC).

Genetic tests advertised directly to the consumer

Jul 21, 2009

Genetic testing services have recently begun to be advertised directly to the patient, and the results of the consumers' response can affect public health, as well as the future adoption of pharmacogenetic/genomic testing, ...

Recommended for you

Despite risks, benzodiazepine use highest in older people

13 hours ago

Prescription use of benzodiazepines—a widely used class of sedative and anti-anxiety medications—increases steadily with age, despite the known risks for older people, according to a comprehensive analysis of benzodiazepine ...

Why some antidepressants may initially worsen symptoms

17 hours ago

New research helps explain a paradoxical effect of certain antidepressants—that they may actually worsen symptoms before helping patients feel better. The findings, highlighted in a paper publishing online December 17 in ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.